1. Market Research
  2. > Merger and Acquisition Deals and Alliances of 2014

Merger and Acquisition Deals and Alliances of 2014

  • March 2015
  • -
  • Currentpartnering
  • -
  • 200 pages

The Merger and Acquisition Deals of 2014 provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare companies during 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the M&A activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2014’s M&A dealmaking and business activities.

Chapter 1 provides an overview of the trends in M&A dealmaking during 2014.

Chapter 2 provides a review of the leading M&A deals during 2014. Deals are listed by headline value, signed by big pharma and big biotech, and most active biopharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 3 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of 2014 M&A deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all M&A deals announced during 2014.

The chapter is organized by company A-Z. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma M&A dealmaking during 2014.

In conclusion, this report provides everything a prospective M&A dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014

Table Of Contents

Merger and Acquisition Deals and Alliances of 2014
Executive Summary

Chapter 1 - Trends in MandA dealmaking during 2014

1.1. Dealmaking activity by month
1.2. MandA by therapy area
1.3. MandA by industry sector

Chapter 2 - Leading MandA deals during 2014

2.1. Introduction
2.2. Top deals by value during 2014
2.3 Most active MandA dealmakers during 2014

Chapter 3 - Big pharma MandA deals during 2014

3.1. Introduction
3.2. How to use big pharma MandA deals
3.3. Big pharma MandA company profiles for 2014
Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson and Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck and Co
Merck KGaA
Mitsubishi Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson

Chapter 4 - MandA deals directory 2014

4.1. Introduction
4.2. Company A-Z

About Wildwood Ventures

Current Partnering
Current Agreements
Current Reports
Recent titles from CurrentPartnering
Order Form - Reports

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.